| The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to vaccine approvals. The nation’s top vaccine regulator, Vinay Prasad, told Moderna that it lacked an “adequate and well-controlled” study, the company said in a news release Tuesday. | 
